Studies with atezolizumab (anti-PD-L1) have used an anti-human PD-L1 monoclonal antibody (Clone SP142) but instead of analyzing tumor cell, immune cell (IC) were studied (all types of ICs, including macrophages, dendritic cells, and lymphocytes, were counted together). Here, CD274 is linked to neoplasm.